Why AI did Not Accelerate Your Drug Design

AI media image

I already tried generative AI, target structures, and other deep learning models. But no acceleration is seen. Why?

Key Function was Missing from AI Models Based on QSAR, Ligands, and Target Structures


These theories have decades of history, but applications of such models are restricted.

In real-world drug design, their performance is also largely compromised.

Illustration